Pharma Aids Limited (DSE:PHARMAID)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
488.20
+4.10 (0.85%)
At close: Jan 1, 2026

Pharma Aids Ratios and Metrics

Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
1,5231,6712,0862,4672,5431,241
Upgrade
Market Cap Growth
-18.16%-19.89%-15.46%-2.98%104.82%-2.50%
Upgrade
Enterprise Value
1,5041,6512,0392,4592,5021,228
Upgrade
Last Close Price
488.20532.40661.81781.79800.73387.17
Upgrade
PE Ratio
22.6026.1834.09-73.1424.70
Upgrade
PS Ratio
3.363.814.958.007.874.43
Upgrade
PB Ratio
3.363.866.088.668.254.27
Upgrade
P/TBV Ratio
3.363.866.088.668.254.27
Upgrade
P/FCF Ratio
178.15-92.27487.6587.2558.77
Upgrade
P/OCF Ratio
23.0542.0291.53339.4775.1339.53
Upgrade
EV/Sales Ratio
3.323.774.847.977.744.38
Upgrade
EV/EBITDA Ratio
15.5318.3622.34134.4540.4616.47
Upgrade
EV/EBIT Ratio
16.7519.7924.18230.5646.3218.52
Upgrade
EV/FCF Ratio
175.95-90.23485.9985.8458.15
Upgrade
Debt / Equity Ratio
0.050.060.050.040.000.00
Upgrade
Debt / EBITDA Ratio
0.210.300.200.630.020.00
Upgrade
Debt / FCF Ratio
2.43-0.802.270.030.01
Upgrade
Asset Turnover
0.810.830.980.810.890.85
Upgrade
Inventory Turnover
4.424.884.924.274.265.48
Upgrade
Quick Ratio
1.421.331.361.772.503.47
Upgrade
Current Ratio
3.033.333.063.264.325.17
Upgrade
Return on Equity (ROE)
16.56%16.46%19.50%-2.15%11.60%18.32%
Upgrade
Return on Assets (ROA)
10.04%9.83%12.24%1.75%9.35%12.60%
Upgrade
Return on Capital (ROIC)
13.14%12.71%16.04%2.20%11.24%14.97%
Upgrade
Return on Capital Employed (ROCE)
19.70%19.20%24.60%3.70%17.50%22.80%
Upgrade
Earnings Yield
4.42%3.82%2.93%-0.26%1.37%4.05%
Upgrade
FCF Yield
0.56%-1.04%1.08%0.21%1.15%1.70%
Upgrade
Dividend Yield
0.61%0.56%0.38%0.13%0.62%1.29%
Upgrade
Payout Ratio
11.37%12.01%7.90%-72.69%29.94%
Upgrade
Total Shareholder Return
0.62%0.56%0.38%0.13%0.62%1.29%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.